Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Mar 7, 2016 at 12:20 PM EST

Why InVivo Therapeutics Soared

InVivo Therapeutics saw its shares surge by over 25% Monday on a pivotal announcement from its Inspire study.

Chris Lange | Mar 7, 2016 at 11:40 AM EST

Is This the Start of the Final Implosion at Celldex?

Celldex Therapeutics Inc. (NASDAQ: CLDX) got burned in Monday’s regular trading session and ultimately saw its shares fall by over…

Chris Lange | Mar 7, 2016 at 11:20 AM EST

Has Valeant Finally Become More Trustworthy?

In Monday's trading session, it seems that investors are finally coming around and trusting Valeant Pharmaceuticals.

Chris Lange | Mar 6, 2016 at 10:40 AM EST

3 Top Biopharma Movers of the Past Week

Over the past week, Halozyme Therapeutics and a couple of other biotech companies made impressive runs.

Chris Lange | Mar 2, 2016 at 11:05 AM EST

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

Canaccord Genuity has downgraded Valeant Pharmaceuticals due to the growing uncertainty surrounding its multitude of investigations, both internal and external.

Chris Lange | Mar 1, 2016 at 11:15 AM EST

Medtronic Earnings Fail to Impress Investors

Medtronic released its fiscal third-quarter earnings report before the markets opened on Tuesday and shares tumbled.

Chris Lange | Feb 29, 2016 at 1:10 PM EST

What to Look for in Medtronic Earnings

Medtronic is scheduled to report its fiscal third-quarter financial results before the markets open on Tuesday.

Chris Lange | Feb 29, 2016 at 11:15 AM EST

Novavax Whiffs on Earnings Results

Novavax reported disappointing fourth-quarter financial results before the markets opened on Monday.

Lee Jackson | Feb 29, 2016 at 10:45 AM EST

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…

Chris Lange | Feb 29, 2016 at 8:55 AM EST

Chimerix Rises Slightly on Revenue Beat

Chimerix reported mixed fourth-quarter financial results before the markets opened on Monday.

Douglas A. McIntyre | Feb 29, 2016 at 6:22 AM EST

Returning Valeant CEO Pearson Needs to Be Fired

Valeant Pharmaceuticals International Inc. (NYSE: VRX) CEO J. Michael Pearson has returned from sick leave. It is a wonder the board…

Chris Lange | Feb 28, 2016 at 10:45 AM EST

How Analysts Changed Views on BioMarin After Earnings

Investors really took to BioMarin Pharmaceuticals stock and there was a favorable jump after the fourth-quarter earnings report.

Chris Lange | Feb 28, 2016 at 10:40 AM EST

Top 4 Biopharma Movers of the Past Week

Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs, due to positive trial results…

Douglas A. McIntyre | Feb 28, 2016 at 10:08 AM EST

The 5 States Where People Get the Least Sleep

Eight hours of sleep. That is the rule most often mentioned as the measure of a good night’s sleep. Some…

Chris Lange | Feb 26, 2016 at 12:50 PM EST

Syndax Updates IPO FIling

Syndax Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

1 … 220 221 222 223 224 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why InVivo Therapeutics Soared

Is This the Start of the Final Implosion at Celldex?

Has Valeant Finally Become More Trustworthy?

3 Top Biopharma Movers of the Past Week

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

Medtronic Earnings Fail to Impress Investors

What to Look for in Medtronic Earnings

Novavax Whiffs on Earnings Results

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

Chimerix Rises Slightly on Revenue Beat

Returning Valeant CEO Pearson Needs to Be Fired

How Analysts Changed Views on BioMarin After Earnings

Top 4 Biopharma Movers of the Past Week

The 5 States Where People Get the Least Sleep

Syndax Updates IPO FIling

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Google Moves to Sell TPUs Directly: A Major Shift That Might Pressure NVIDIA’s AI Compute Dominance

Bitcoin Breaks $80K but Ripple (XRP) Is Lagging Again: Why Isn’t Capital Rotation Happening?

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Health and Healthcare Articles

All Health and Healthcare Articles

Why InVivo Therapeutics Soared

Is This the Start of the Final Implosion at Celldex?

Has Valeant Finally Become More Trustworthy?

3 Top Biopharma Movers of the Past Week

Why Key Analyst Still Sees Upside in Valeant Despite Downgrade

Medtronic Earnings Fail to Impress Investors

What to Look for in Medtronic Earnings

Novavax Whiffs on Earnings Results

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

Chimerix Rises Slightly on Revenue Beat

Returning Valeant CEO Pearson Needs to Be Fired

How Analysts Changed Views on BioMarin After Earnings

Top 4 Biopharma Movers of the Past Week

The 5 States Where People Get the Least Sleep

Syndax Updates IPO FIling

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Google Moves to Sell TPUs Directly: A Major Shift That Might Pressure NVIDIA’s AI Compute Dominance

Bitcoin Breaks $80K but Ripple (XRP) Is Lagging Again: Why Isn’t Capital Rotation Happening?

Featured Reads

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House